FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2041364571> ?p ?o ?g. }

• W2041364571 endingPage "1894" @default.
• W2041364571 startingPage "1893" @default.
• W2041364571 abstract "We report a 65-year-old man presenting with recurrent pulmonary metastases 20 years after an appendectomy for mucinous cystadenocarcinoma with pseudomyxomatous peritonei. He underwent bilateral staged metastatectomies for metastases 7 years after the diagnosis and further metastasectomy after a recent recurrence. This is a rare case of recurrent pulmonary metastatic mucinous cystadenocarcinoma, and despite poor prognosis and nondefinitive initial treatment, this patient remains alive and well 20 years later. We report a 65-year-old man presenting with recurrent pulmonary metastases 20 years after an appendectomy for mucinous cystadenocarcinoma with pseudomyxomatous peritonei. He underwent bilateral staged metastatectomies for metastases 7 years after the diagnosis and further metastasectomy after a recent recurrence. This is a rare case of recurrent pulmonary metastatic mucinous cystadenocarcinoma, and despite poor prognosis and nondefinitive initial treatment, this patient remains alive and well 20 years later. The long-term prognosis of appendiceal mucinous cystadenocarcinoma (MCA) with pseudomyxomatous peritonei (PMP) is poor in the absence of radical therapy. Rarely, presentation with pulmonary metastasis is seen.A 65-year-old man initially presented with an acute abdomen and underwent laparotomy in 1985. He was found to have a ruptured appendix mucocele and PMP, and an appendicectomy was performed. Histopathology revealed the appendix mass to be MCA. Radiotherapy was subsequently given to his abdomen. He recovered uneventfully, but was lost to follow-up.Seven years later in 1992, a chest roentgenogram taken to investigate persistent cough revealed bilateral pulmonary lesions. Computed tomography (CT) showed a large mass in his right upper lobe and two lesions in his left lung. No recurrence of disease was seen in the abdomen.Staged resections were performed through a bilateral thoracotomy. The first was a right-sided operation that revealed a 10-cm lesion containing gelatinous material distending the upper lobe bronchus, with lung consolidation and abscess formation. A right upper lobectomy with sleeve resection was performed.A left thoracotomy 3 months later revealed a 6-cm tumor within the lingula and a 3-cm tumor located in the lower lobe. A lingulectomy removing the upper lobe mass and metastasectomy of the lower lobe mass were performed. Pathology confirmed these lesions were metastatic MCA appendix deposits. Recovery was uneventful, but again he was lost to follow-up.Thereafter in 2005, he was investigated for breathlessness and chest roentgenogram showed a new right-sided lesion. Chest CT and positron emission tomography confirmed a large, lower lobe apical segmental tumor (Fig 1). The forced expiratory volume in 1 second (FEV1) was measured at 1.1 liters. Metastasectomy was subsequently performed through a redo thoracotomy. Pathology revealed the lesion to be MCA (Fig 2) . Immunostaining was positive for CK-20 and negative for CK-7, and thyroid transcription factor-1 antibodies confirmed its abdominal origin rather than being primary lung MCA (Fig 3).Fig 2Hematoxylin and eosin staining shows the tumor consists of lakes of mucin lined by goblet cells and set within a fibrous stroma (×200 original magnification).View Large Image Figure ViewerDownload (PPT)Fig 3Immunohistochemical section from recent lung metastasis specimen stained positive for cytokeratin-20 antibody, confirming the abdominal origin of the mucinous cystadenocarcinoma (×200 original magnification).View Large Image Figure ViewerDownload (PPT)The patient was reviewed 9 months after this operation. The chest roentgenogram was satisfactory, he has good exercise tolerance, and his FEV1 remains at 1.1 liters.CommentPMP results from rupture of an appendix mucocele. Appendiceal mucoceles in turn can result from benign (cyst, mucosal hyperplasia, cystadenoma) or malignant (cystadenocarcinoma) processes. The incidence of malignant appendiceal tumors is as high as 0.5% of appendicectomy specimens. Of these, MCAs represent about 8% [1Deans G.T. Spence R.A. Neoplastic lesions of the appendix.Br J Surg. 1995; 82: 299-306Crossref PubMed Scopus (184) Google Scholar]. They are a cystic variant of adenocarcinoma and produce copious mucus. The prognosis of MCA presenting with PMP is poor [2Sugarbaker P.H. Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy.Ann Surg Oncol. 1999; 6: 727-731Crossref PubMed Scopus (507) Google Scholar].Although intraabdominal and pelvic spread is common, extraabdominal spread is uncommon. Sporadic reports of metastasis from MCA appendix to other organs exist [3Dhage-Ivatury S. Sugarbaker P.H. Update on the surgical approach to mucocele of the appendix.J Am Coll Surg. 2006; 202: 680-684Abstract Full Text Full Text PDF PubMed Scopus (135) Google Scholar]. Pulmonary metastasis is extremely rare, with only a handful of cases reported [4Mortman K.D. Sugarbaker P.A. Shmookler B.M. DeGuzman V.C. Soberman M.S. Pulmonary metastases in pseudomyxoma peritonei syndrome.Ann Thorac Surg. 1997; 64: 1434-1436Abstract Full Text Full Text PDF PubMed Scopus (24) Google Scholar, 5Lee B.Y. Kim H.S. Lee S.H. et al.Pseudomyxoma peritonei: extraperitoneal spread to the pleural cavity and lung.J Thorac Imaging. 2004; 19: 123-126Crossref PubMed Scopus (18) Google Scholar].Surgical treatment of MCA appendix presenting with PMP usually consists of right hemicolectomy if the primary tumor (mucocele) appears malignant and appendicectomy if it appears benign. This could be a difficult decision to make.More recent protocols consist of aggressive cytoreductive surgery, including total omentectomy, and often splenectomy, rectosigmoid colectomy, and resection of other involved organs, followed by heated intraperitoneal chemotherapy. This treatment has been pioneered and developed by Sugarbaker and colleagues [2Sugarbaker P.H. Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy.Ann Surg Oncol. 1999; 6: 727-731Crossref PubMed Scopus (507) Google Scholar], who have just reported a 63% survival at 5 years from a series of 385 patients treated with this approach. The natural history of this disease is such that they state “in the absence of this [cytoreductive surgery and intraperitoneal chemotherapy] approach no long term survivors have ever been reported in the medical literature” [3Dhage-Ivatury S. Sugarbaker P.H. Update on the surgical approach to mucocele of the appendix.J Am Coll Surg. 2006; 202: 680-684Abstract Full Text Full Text PDF PubMed Scopus (135) Google Scholar].Mortman and colleagues [4Mortman K.D. Sugarbaker P.A. Shmookler B.M. DeGuzman V.C. Soberman M.S. Pulmonary metastases in pseudomyxoma peritonei syndrome.Ann Thorac Surg. 1997; 64: 1434-1436Abstract Full Text Full Text PDF PubMed Scopus (24) Google Scholar] have also reported 3 patients with metastatic pulmonary MCA appendix. All underwent initial cytoreductive surgery with heated intraperitoneal chemotherapy. On discovering their lung metastases on follow-up, 2 patients underwent further lobectomy with lymphadenectomy and 1 was treated with wedge resection. All were reported as being disease-free at 2 to 8 years of follow-up.The case presented here reports recurrent pulmonary metastatic MCA appendix and is one of a handful of cases of pulmonary metastases reported in the literature to date. Also, despite receiving suboptimal treatment at presentation compared with recent opinion, this patient has defied all known expectations and is currently well 20 years after initial diagnosis. Finally, serial metastasectomy was well tolerated, with no deterioration in lung function. This observation was probably due to excision of nonfunctional lung tissue, allowing remaining viable lung to expand.In conclusion, pulmonary metastasis of appendiceal MCA with PMP is very rare. Moreover, recurrence can occur many years after initial presentation, suggesting that such patients should have lifelong follow-up with at least an annual chest roentgenogram. Serial lung metastasectomy is well tolerated but cannot be regarded as curative. Also, this case of prolonged survival challenges currently accepted views of the natural history of this disease. The long-term prognosis of appendiceal mucinous cystadenocarcinoma (MCA) with pseudomyxomatous peritonei (PMP) is poor in the absence of radical therapy. Rarely, presentation with pulmonary metastasis is seen. A 65-year-old man initially presented with an acute abdomen and underwent laparotomy in 1985. He was found to have a ruptured appendix mucocele and PMP, and an appendicectomy was performed. Histopathology revealed the appendix mass to be MCA. Radiotherapy was subsequently given to his abdomen. He recovered uneventfully, but was lost to follow-up. Seven years later in 1992, a chest roentgenogram taken to investigate persistent cough revealed bilateral pulmonary lesions. Computed tomography (CT) showed a large mass in his right upper lobe and two lesions in his left lung. No recurrence of disease was seen in the abdomen. Staged resections were performed through a bilateral thoracotomy. The first was a right-sided operation that revealed a 10-cm lesion containing gelatinous material distending the upper lobe bronchus, with lung consolidation and abscess formation. A right upper lobectomy with sleeve resection was performed. A left thoracotomy 3 months later revealed a 6-cm tumor within the lingula and a 3-cm tumor located in the lower lobe. A lingulectomy removing the upper lobe mass and metastasectomy of the lower lobe mass were performed. Pathology confirmed these lesions were metastatic MCA appendix deposits. Recovery was uneventful, but again he was lost to follow-up. Thereafter in 2005, he was investigated for breathlessness and chest roentgenogram showed a new right-sided lesion. Chest CT and positron emission tomography confirmed a large, lower lobe apical segmental tumor (Fig 1). The forced expiratory volume in 1 second (FEV1) was measured at 1.1 liters. Metastasectomy was subsequently performed through a redo thoracotomy. Pathology revealed the lesion to be MCA (Fig 2) . Immunostaining was positive for CK-20 and negative for CK-7, and thyroid transcription factor-1 antibodies confirmed its abdominal origin rather than being primary lung MCA (Fig 3). The patient was reviewed 9 months after this operation. The chest roentgenogram was satisfactory, he has good exercise tolerance, and his FEV1 remains at 1.1 liters. CommentPMP results from rupture of an appendix mucocele. Appendiceal mucoceles in turn can result from benign (cyst, mucosal hyperplasia, cystadenoma) or malignant (cystadenocarcinoma) processes. The incidence of malignant appendiceal tumors is as high as 0.5% of appendicectomy specimens. Of these, MCAs represent about 8% [1Deans G.T. Spence R.A. Neoplastic lesions of the appendix.Br J Surg. 1995; 82: 299-306Crossref PubMed Scopus (184) Google Scholar]. They are a cystic variant of adenocarcinoma and produce copious mucus. The prognosis of MCA presenting with PMP is poor [2Sugarbaker P.H. Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy.Ann Surg Oncol. 1999; 6: 727-731Crossref PubMed Scopus (507) Google Scholar].Although intraabdominal and pelvic spread is common, extraabdominal spread is uncommon. Sporadic reports of metastasis from MCA appendix to other organs exist [3Dhage-Ivatury S. Sugarbaker P.H. Update on the surgical approach to mucocele of the appendix.J Am Coll Surg. 2006; 202: 680-684Abstract Full Text Full Text PDF PubMed Scopus (135) Google Scholar]. Pulmonary metastasis is extremely rare, with only a handful of cases reported [4Mortman K.D. Sugarbaker P.A. Shmookler B.M. DeGuzman V.C. Soberman M.S. Pulmonary metastases in pseudomyxoma peritonei syndrome.Ann Thorac Surg. 1997; 64: 1434-1436Abstract Full Text Full Text PDF PubMed Scopus (24) Google Scholar, 5Lee B.Y. Kim H.S. Lee S.H. et al.Pseudomyxoma peritonei: extraperitoneal spread to the pleural cavity and lung.J Thorac Imaging. 2004; 19: 123-126Crossref PubMed Scopus (18) Google Scholar].Surgical treatment of MCA appendix presenting with PMP usually consists of right hemicolectomy if the primary tumor (mucocele) appears malignant and appendicectomy if it appears benign. This could be a difficult decision to make.More recent protocols consist of aggressive cytoreductive surgery, including total omentectomy, and often splenectomy, rectosigmoid colectomy, and resection of other involved organs, followed by heated intraperitoneal chemotherapy. This treatment has been pioneered and developed by Sugarbaker and colleagues [2Sugarbaker P.H. Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy.Ann Surg Oncol. 1999; 6: 727-731Crossref PubMed Scopus (507) Google Scholar], who have just reported a 63% survival at 5 years from a series of 385 patients treated with this approach. The natural history of this disease is such that they state “in the absence of this [cytoreductive surgery and intraperitoneal chemotherapy] approach no long term survivors have ever been reported in the medical literature” [3Dhage-Ivatury S. Sugarbaker P.H. Update on the surgical approach to mucocele of the appendix.J Am Coll Surg. 2006; 202: 680-684Abstract Full Text Full Text PDF PubMed Scopus (135) Google Scholar].Mortman and colleagues [4Mortman K.D. Sugarbaker P.A. Shmookler B.M. DeGuzman V.C. Soberman M.S. Pulmonary metastases in pseudomyxoma peritonei syndrome.Ann Thorac Surg. 1997; 64: 1434-1436Abstract Full Text Full Text PDF PubMed Scopus (24) Google Scholar] have also reported 3 patients with metastatic pulmonary MCA appendix. All underwent initial cytoreductive surgery with heated intraperitoneal chemotherapy. On discovering their lung metastases on follow-up, 2 patients underwent further lobectomy with lymphadenectomy and 1 was treated with wedge resection. All were reported as being disease-free at 2 to 8 years of follow-up.The case presented here reports recurrent pulmonary metastatic MCA appendix and is one of a handful of cases of pulmonary metastases reported in the literature to date. Also, despite receiving suboptimal treatment at presentation compared with recent opinion, this patient has defied all known expectations and is currently well 20 years after initial diagnosis. Finally, serial metastasectomy was well tolerated, with no deterioration in lung function. This observation was probably due to excision of nonfunctional lung tissue, allowing remaining viable lung to expand.In conclusion, pulmonary metastasis of appendiceal MCA with PMP is very rare. Moreover, recurrence can occur many years after initial presentation, suggesting that such patients should have lifelong follow-up with at least an annual chest roentgenogram. Serial lung metastasectomy is well tolerated but cannot be regarded as curative. Also, this case of prolonged survival challenges currently accepted views of the natural history of this disease. PMP results from rupture of an appendix mucocele. Appendiceal mucoceles in turn can result from benign (cyst, mucosal hyperplasia, cystadenoma) or malignant (cystadenocarcinoma) processes. The incidence of malignant appendiceal tumors is as high as 0.5% of appendicectomy specimens. Of these, MCAs represent about 8% [1Deans G.T. Spence R.A. Neoplastic lesions of the appendix.Br J Surg. 1995; 82: 299-306Crossref PubMed Scopus (184) Google Scholar]. They are a cystic variant of adenocarcinoma and produce copious mucus. The prognosis of MCA presenting with PMP is poor [2Sugarbaker P.H. Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy.Ann Surg Oncol. 1999; 6: 727-731Crossref PubMed Scopus (507) Google Scholar]. Although intraabdominal and pelvic spread is common, extraabdominal spread is uncommon. Sporadic reports of metastasis from MCA appendix to other organs exist [3Dhage-Ivatury S. Sugarbaker P.H. Update on the surgical approach to mucocele of the appendix.J Am Coll Surg. 2006; 202: 680-684Abstract Full Text Full Text PDF PubMed Scopus (135) Google Scholar]. Pulmonary metastasis is extremely rare, with only a handful of cases reported [4Mortman K.D. Sugarbaker P.A. Shmookler B.M. DeGuzman V.C. Soberman M.S. Pulmonary metastases in pseudomyxoma peritonei syndrome.Ann Thorac Surg. 1997; 64: 1434-1436Abstract Full Text Full Text PDF PubMed Scopus (24) Google Scholar, 5Lee B.Y. Kim H.S. Lee S.H. et al.Pseudomyxoma peritonei: extraperitoneal spread to the pleural cavity and lung.J Thorac Imaging. 2004; 19: 123-126Crossref PubMed Scopus (18) Google Scholar]. Surgical treatment of MCA appendix presenting with PMP usually consists of right hemicolectomy if the primary tumor (mucocele) appears malignant and appendicectomy if it appears benign. This could be a difficult decision to make. More recent protocols consist of aggressive cytoreductive surgery, including total omentectomy, and often splenectomy, rectosigmoid colectomy, and resection of other involved organs, followed by heated intraperitoneal chemotherapy. This treatment has been pioneered and developed by Sugarbaker and colleagues [2Sugarbaker P.H. Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy.Ann Surg Oncol. 1999; 6: 727-731Crossref PubMed Scopus (507) Google Scholar], who have just reported a 63% survival at 5 years from a series of 385 patients treated with this approach. The natural history of this disease is such that they state “in the absence of this [cytoreductive surgery and intraperitoneal chemotherapy] approach no long term survivors have ever been reported in the medical literature” [3Dhage-Ivatury S. Sugarbaker P.H. Update on the surgical approach to mucocele of the appendix.J Am Coll Surg. 2006; 202: 680-684Abstract Full Text Full Text PDF PubMed Scopus (135) Google Scholar]. Mortman and colleagues [4Mortman K.D. Sugarbaker P.A. Shmookler B.M. DeGuzman V.C. Soberman M.S. Pulmonary metastases in pseudomyxoma peritonei syndrome.Ann Thorac Surg. 1997; 64: 1434-1436Abstract Full Text Full Text PDF PubMed Scopus (24) Google Scholar] have also reported 3 patients with metastatic pulmonary MCA appendix. All underwent initial cytoreductive surgery with heated intraperitoneal chemotherapy. On discovering their lung metastases on follow-up, 2 patients underwent further lobectomy with lymphadenectomy and 1 was treated with wedge resection. All were reported as being disease-free at 2 to 8 years of follow-up. The case presented here reports recurrent pulmonary metastatic MCA appendix and is one of a handful of cases of pulmonary metastases reported in the literature to date. Also, despite receiving suboptimal treatment at presentation compared with recent opinion, this patient has defied all known expectations and is currently well 20 years after initial diagnosis. Finally, serial metastasectomy was well tolerated, with no deterioration in lung function. This observation was probably due to excision of nonfunctional lung tissue, allowing remaining viable lung to expand. In conclusion, pulmonary metastasis of appendiceal MCA with PMP is very rare. Moreover, recurrence can occur many years after initial presentation, suggesting that such patients should have lifelong follow-up with at least an annual chest roentgenogram. Serial lung metastasectomy is well tolerated but cannot be regarded as curative. Also, this case of prolonged survival challenges currently accepted views of the natural history of this disease." @default.
• W2041364571 created "2016-06-24" @default.
• W2041364571 creator A5024234378 @default.
• W2041364571 creator A5030881570 @default.
• W2041364571 creator A5049672571 @default.
• W2041364571 creator A5061551266 @default.
• W2041364571 date "2007-05-01" @default.
• W2041364571 modified "2023-10-16" @default.
• W2041364571 title "Prolonged Survival in a Patient With Recurrent Pulmonary Metastases Secondary to Mucinous Cystadenocarcinoma of the Appendix With Pseudomyxomatous Peritonei" @default.
• W2041364571 cites W1969397704 @default.
• W2041364571 cites W1989627942 @default.
• W2041364571 cites W2040252868 @default.
• W2041364571 cites W2062408501 @default.
• W2041364571 cites W2067723465 @default.
• W2041364571 doi "https://doi.org/10.1016/j.athoracsur.2006.12.015" @default.
• W2041364571 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17462430" @default.
• W2041364571 hasPublicationYear "2007" @default.
• W2041364571 type Work @default.
• W2041364571 sameAs 2041364571 @default.
• W2041364571 citedByCount "6" @default.
• W2041364571 countsByYear W20413645712012 @default.
• W2041364571 countsByYear W20413645712013 @default.
• W2041364571 countsByYear W20413645712017 @default.
• W2041364571 countsByYear W20413645712019 @default.
• W2041364571 countsByYear W20413645712023 @default.
• W2041364571 crossrefType "journal-article" @default.
• W2041364571 hasAuthorship W2041364571A5024234378 @default.
• W2041364571 hasAuthorship W2041364571A5030881570 @default.
• W2041364571 hasAuthorship W2041364571A5049672571 @default.
• W2041364571 hasAuthorship W2041364571A5061551266 @default.
• W2041364571 hasConcept C121608353 @default.
• W2041364571 hasConcept C126322002 @default.
• W2041364571 hasConcept C151730666 @default.
• W2041364571 hasConcept C2776364125 @default.
• W2041364571 hasConcept C2778164203 @default.
• W2041364571 hasConcept C2778324911 @default.
• W2041364571 hasConcept C2780898957 @default.
• W2041364571 hasConcept C2780964533 @default.
• W2041364571 hasConcept C2781182431 @default.
• W2041364571 hasConcept C61434518 @default.
• W2041364571 hasConcept C71924100 @default.
• W2041364571 hasConcept C86803240 @default.
• W2041364571 hasConceptScore W2041364571C121608353 @default.
• W2041364571 hasConceptScore W2041364571C126322002 @default.
• W2041364571 hasConceptScore W2041364571C151730666 @default.
• W2041364571 hasConceptScore W2041364571C2776364125 @default.
• W2041364571 hasConceptScore W2041364571C2778164203 @default.
• W2041364571 hasConceptScore W2041364571C2778324911 @default.
• W2041364571 hasConceptScore W2041364571C2780898957 @default.
• W2041364571 hasConceptScore W2041364571C2780964533 @default.
• W2041364571 hasConceptScore W2041364571C2781182431 @default.
• W2041364571 hasConceptScore W2041364571C61434518 @default.
• W2041364571 hasConceptScore W2041364571C71924100 @default.
• W2041364571 hasConceptScore W2041364571C86803240 @default.
• W2041364571 hasIssue "5" @default.
• W2041364571 hasLocation W20413645711 @default.
• W2041364571 hasLocation W20413645712 @default.
• W2041364571 hasOpenAccess W2041364571 @default.
• W2041364571 hasPrimaryLocation W20413645711 @default.
• W2041364571 hasRelatedWork W153446488 @default.
• W2041364571 hasRelatedWork W1997641547 @default.
• W2041364571 hasRelatedWork W2068659839 @default.
• W2041364571 hasRelatedWork W2314302016 @default.
• W2041364571 hasRelatedWork W2331283110 @default.
• W2041364571 hasRelatedWork W2334507109 @default.
• W2041364571 hasRelatedWork W2404130655 @default.
• W2041364571 hasRelatedWork W2465886614 @default.
• W2041364571 hasRelatedWork W2610082826 @default.
• W2041364571 hasRelatedWork W2969357081 @default.
• W2041364571 hasVolume "83" @default.
• W2041364571 isParatext "false" @default.
• W2041364571 isRetracted "false" @default.
• W2041364571 magId "2041364571" @default.
• W2041364571 workType "article" @default.